State Street SPDR S&P Pharmaceuticals ETF (NY:XPH)
Price and Volume
Detailed Quote| Volume | 10 |
| Open | 50.21 |
| Bid (Size) | 48.23 (100) |
| Ask (Size) | 51.84 (400) |
| Prev. Close | 50.21 |
| Today's Range | 50.21 - 50.21 |
| 52wk Range | 35.22 - 51.56 |
| Shares Outstanding | 36,002 |
| Dividend Yield | 0.82% |
Top News
More News
Performance
More News
Read More
Pharma Tariffs Back In Spotlight On New Trump Threat ↗
September 26, 2025
ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot ↗
April 18, 2025
Biopharma: A 'Safe Haven' As Tariff Turmoil Rages On? ↗
April 03, 2025
Frequently Asked Questions
Is State Street SPDR S&P Pharmaceuticals ETF publicly traded?
Yes, State Street SPDR S&P Pharmaceuticals ETF is publicly traded.
What exchange does State Street SPDR S&P Pharmaceuticals ETF trade on?
State Street SPDR S&P Pharmaceuticals ETF trades on the New York Stock Exchange
What is the ticker symbol for State Street SPDR S&P Pharmaceuticals ETF?
The ticker symbol for State Street SPDR S&P Pharmaceuticals ETF is XPH on the New York Stock Exchange
What is the current price of State Street SPDR S&P Pharmaceuticals ETF?
The current price of State Street SPDR S&P Pharmaceuticals ETF is 50.21
When was State Street SPDR S&P Pharmaceuticals ETF last traded?
The last trade of State Street SPDR S&P Pharmaceuticals ETF was at 11/13/25 08:00 PM ET
What is the market capitalization of State Street SPDR S&P Pharmaceuticals ETF?
The market capitalization of State Street SPDR S&P Pharmaceuticals ETF is 1.81M
How many shares of State Street SPDR S&P Pharmaceuticals ETF are outstanding?
State Street SPDR S&P Pharmaceuticals ETF has 2M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Copyright 2024. BUSINESS INSURANCE HOLDINGS
